Escitalopram (escitalopram oxalate 20 mg) Dailymed
Generic: escitalopram is used for the treatment of Depressive Disorder, Major
IMPRINT: 5852 20
SHAPE: round
COLOR: white SCORE: 2
Go PRO for all pill images
Label Display
NDC: 51655-151-52
MFG: 0093-5852-05
Escitalopram 20 mg
30 tablets
Rx only
Lot#:
Exp. Date:
Each tablet contains: escitalopram oxalate, USP equivalent to 20 mg escitalopram
Dosage: See package insert
Store at 6877 degrees F.
Store in a tight, light-resistant container (See USP). Keep out of the reach of children.
Mfg by: Cipla Ltd, Kurkumbh, India
Mfg for: Teva Pharmaceuticals USA, Sellersville, PA 18960 Lot#:
Repackaged by Northwind Pharmaceuticals, Indianapolis, IN 46256
Indications And Usage
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for:
Acute and Maintenance Treatment of Major Depressive Disorder (MDD) in adults and adolescents aged 12 to 17 years
Acute Treatment of Generalized Anxiety Disorder (GAD) in adults
Contraindications
Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with escitalopram or within 14 days of stopping treatment with escitalopram.
Do not use escitalopram within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start escitalopram in a patient who is being treated with linezolid or intravenous methylene blue.
Pimozide: Do not use concomitantly.
Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients
Warnings And Precautions
Clinical Worsening/Suicide Risk: Monitor for clinical worsening, suicidality and unusual change in behavior, especially during the initial few months of therapy or at times of dose changes .
Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including escitalopram, both when taken alone, but especially when coadministered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone and St. John’s Wort). If such symptoms occur, discontinue escitalopram and initiate supportive treatment. If concomitant use of escitalopram with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases.
Discontinuation of Treatment with Escitalopram: A gradual reduction in dose rather than abrupt cessation is recommended whenever possible.
Seizures: Prescribe with care in patients with a history of seizure.
Activation of Mania/Hypomania: Use cautiously in patients with a history of mania.
Hyponatremia: Can occur in association with SIADH (5.6).Abnormal Bleeding: Use caution in concomitant use with NSAIDs, aspirin, warfarin or other drugs that affect coagulation.
Interference with Cognitive and Motor Performance: Use caution when operating machinery.
Use in Patients with Concomitant Illness: Use caution in patients with diseases or conditions that produce altered metabolism or hemodynamic responses
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
